Fischer Medical Ventures Limited has informed the Exchange regarding a press release dated July 10, 2025, titled "Fischer Medical Ventures Ltd partners with City of Jember to Power Indonesia s Fight Against Tuberculosis".
FISCHER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fischer Medical Ventures Ltd (FMV) announced a public-private partnership with the City of Jember, Indonesia, to deploy portable, AI-enabled digital X-ray systems aimed at eradicating tuberculosis. The handheld devices weigh under 3kg, use low radiation, and have built-in AI algorithms to detect signs of TB in chest X-rays, enabling rapid diagnosis in remote areas. The program is valued at over USD 10 million with phased implementation over 2 years. The initiative targets 'Free TB in Jember by 2026' and supports Indonesia's national goal to eradicate TB by 2030. The project is championed by the Regent of Jember and supported by Indonesia's Minister of Health, positioning FMV strategically in Indonesia's 280-million-population healthcare market.
This marks FMV's strategic entry into Indonesia's large public healthcare market, potentially opening long-term government procurement opportunities. The USD 10 million+ contract provides revenue visibility over 2 years and could enhance brand positioning for further expansion across Indonesian cities, though actual financial impact will depend on execution and follow-on orders.